반응식
Cl[C:2]1[C:3](=[O:16])[N:4]([CH3:15])[S:5](=[O:14])(=[O:13])[C:6]=1[C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1.[NH2:17][C:18]1[CH:19]=[CH:20][C:21]2[O:25][C:24]([C:26](=[O:28])[CH3:27])=[CH:23][C:22]=2[CH:29]=1>>[C:26]([C:24]1[O:25][C:21]2[CH:20]=[CH:19][C:18]([NH:17][C:2]3[C:3](=[O:16])[N:4]([CH3:15])[S:5](=[O:14])(=[O:13])[C:6]=3[C:7]3[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=3)=[CH:29][C:22]=2[CH:23]=1)(=[O:28])[CH3:27]참가 물질
3
실험 절차
The title compound was prepared from 4-chloro-2-methyl-5-phenylisothiazol-3(2H)-one 1,1-dioxide and 1-(5-amino-1-benzofuran-2-yl)ethanone in a similar manner as described for e.g. Examples 9 and 13. 1H NMR (400 MHz, CD3CN): δ 7.89 (bs, 1H), 7.38-7.37 (m, 1H), 7.25 (d, 1H), 7.16-7.10 (m, 4H), 7.09-7.03 (m, 3H), 3.22 (s, 3H), 2.50 (s, 3H); Mass Spectrum: M+H+ 397.
출처 및 근거
- ORD 기록
- ord-d648d65938054e8298ce91262b6cfa66
- 출처 데이터셋
- uspto-grants-2009_09
- 특허 번호
- US07582629B2
연결된 노트
불러오는 중…